Fresenius SE KGaA (XTER:FRE) Additional Paid-In Capital : €4,326 Mil(As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Additional Paid-In Capital?

Fresenius SE KGaA's quarterly additional paid-in capital increased from Jun. 2023 (€4,323 Mil) to Sep. 2023 (€4,325 Mil) and increased from Sep. 2023 (€4,325 Mil) to Dec. 2023 (€4,326 Mil).

Fresenius SE KGaA's annual additional paid-in capital increased from Dec. 2021 (€4,026 Mil) to Dec. 2022 (€4,323 Mil) and increased from Dec. 2022 (€4,323 Mil) to Dec. 2023 (€4,326 Mil).

Fresenius SE KGaA Additional Paid-In Capital Historical Data

The historical data trend for Fresenius SE KGaA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Additional Paid-In Capital Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

3,989.00

3,992.00

4,026.00

4,323.00

4,326.00

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															4,323.00	4,321.00	4,323.00	4,325.00	4,326.00

Fresenius SE KGaA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Fresenius SE KGaA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (XTER:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

FSNUY:USA FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Executives

Dr. Michael Moser	Board of Directors
Sara Hennicken	Board of Directors
Michael Sen	Board of Directors
Dr. Francesco De Meo	Board of Directors
Stephan Sturm	Board of Directors
Wolfgang Kirsch	Supervisory Board
Mats Henriksson	Board of Directors
Dr. Gerd Krick	Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines